Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.

Date Company Event Filing
TEAM INC TISI Material agreement signed Item 1.01 Form 8-K
TEAM INC TISI Regulation FD disclosure Item 7.01 Form 8-K
TON Strategy Co TONX Results announced Item 2.02 Form 8-K
TRANSACT TECHNOLOGIES INC TACT Results announced Item 2.02 Form 8-K
TWIN DISC INC TWIN Officer or director change Item 5.02 Form 8-K
TYSON FOODS, INC. TSN Material agreement signed Item 1.01 Form 8-K
TYSON FOODS, INC. TSN Other event Item 8.01 Form 8-K
Tango Therapeutics, Inc. TNGX Results announced Item 2.02 Form 8-K
Tango Therapeutics, Inc. TNGX Other event Item 8.01 Form 8-K
Taysha Gene Therapies, Inc. TSHA Results announced Item 2.02 Form 8-K
Terrestrial Energy Inc. /DE/ IMSR Results announced Item 2.02 Form 8-K
TherapeuticsMD, Inc. TXMD Results announced Item 2.02 Form 8-K
TherapeuticsMD, Inc. TXMD Regulation FD disclosure Item 7.01 Form 8-K
Theriva Biologics, Inc. TOVX Results announced Item 2.02 Form 8-K
Thryv Holdings, Inc. THRY Officer or director change Item 5.02 Form 8-K
Trulieve Cannabis Corp. TRLV Material agreement signed Item 1.01 Form 8-K
Trulieve Cannabis Corp. TRLV Unregistered share sale Item 3.02 Form 8-K
Trulieve Cannabis Corp. TRLV Shareholder rights changed Item 3.03 Form 8-K
Trulieve Cannabis Corp. TRLV Charter or fiscal year changed Item 5.03 Form 8-K
Twenty One Capital, Inc. XXI Regulation FD disclosure Item 7.01 Form 8-K
UNITED STATES ANTIMONY CORP UAMY Results announced Item 2.02 Form 8-K
Ultragenyx Pharmaceutical Inc. RARE Other event Item 8.01 Form 8-K
Unusual Machines, Inc. UMAC Regulation FD disclosure Item 7.01 Form 8-K
Upstream Bio, Inc. UPB Results announced Item 2.02 Form 8-K
Velo3D, Inc. VELO Results announced Item 2.02 Form 8-K
Velo3D, Inc. VELO Regulation FD disclosure Item 7.01 Form 8-K
Venture Global, Inc. VG Results announced Item 2.02 Form 8-K
Veradermics, Inc MANE Results announced Item 2.02 Form 8-K
Verde Clean Fuels, Inc. VGAS Results announced Item 2.02 Form 8-K
Vestis Corp VSTS Results announced Item 2.02 Form 8-K
Vivos Therapeutics, Inc. VVOS Regulation FD disclosure Item 7.01 Form 8-K
WAFD INC WAFD Other event Item 8.01 Form 8-K
WEC ENERGY GROUP, INC. WEC Officer or director change Item 5.02 Form 8-K
WRAP TECHNOLOGIES, INC. WRAP Results announced Item 2.02 Form 8-K
Wheeler Real Estate Investment Trust, Inc. WHLR Unregistered share sale Item 3.02 Form 8-K
Worksport Ltd WKSP Regulation FD disclosure Item 7.01 Form 8-K
Xtant Medical Holdings, Inc. XTNT Results announced Item 2.02 Form 8-K
Zeo Energy Corp. ZEO Shareholder vote Item 5.07 Form 8-K
Zura Bio Ltd ZURA Results announced Item 2.02 Form 8-K
Zura Bio Ltd ZURA Regulation FD disclosure Item 7.01 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.